Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Capital Leases: 2009-2012

Historic Capital Leases for Northwest Biotherapeutics (NWBO) over the last 3 years, with Dec 2012 value amounting to -$323,000.

  • Northwest Biotherapeutics' Capital Leases changed negligibly% to -$323,000 in Q2 2013 from the same period last year, while for Jun 2013 it was -$323,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of -$323,000 for FY2012, which is N/A change from last year.
  • Latest data reveals that Northwest Biotherapeutics reported Capital Leases of -$323,000 as of FY2012, which was down 0.00% from -$323,000 recorded in FY2010.
  • In the past 5 years, Northwest Biotherapeutics' Capital Leases ranged from a high of -$323,000 in FY2009 and a low of -$323,000 during FY2009.
  • Moreover, its 2-year median value for Capital Leases was -$323,000 (2012), whereas its average is -$323,000.